Article

Viscosurgical device combines the best of both worlds

DisCoVisc (Alcon Laboratories) is appreciated by physicians who have had the opportunity to use it during cataract surgery because of its dispersive and cohesive properties, said panelists in a roundtable discussion held Monday at the Westin Hotel in Chicago.

Chicago-DisCoVisc (Alcon Laboratories) is appreciated by physicians who have had the opportunity to use it during cataract surgery because of its dispersive and cohesive properties, said panelists in a roundtable discussion held Monday at the Westin Hotel in Chicago.

The participants in the roundtable were moderator Steve Brint, MD, New Orleans; Robert Lehmann, MD, Nacogdoches, TX; David Lubeck, MD, Homewood, IL; Kevin Miller, MD, Los Angeles; Jonathan Rubenstein, MD, Chicago; Michael Snyder, MD, Cincinnati; Abhay Vasavada, MS, FRCS, Ahmedabad, India; and Mitch Weikert, MD, Houston.

Besides the convenience of the dispersive and cohesive characteristics in one product, other characteristics that participants like are that it provides the same clarity while in the eye as other products, it is retained well in the eye, and it is easily and rapidly removed.

Many of the physicians said the DisCoVisc was excellent for use in most patients, even those with complicated cases. However, some preferred to use Viscoat for patients with endothelial dysfunction because of the potential for better protection.

Regarding safety, physicians reported IOP levels in the low 20s (mm Hg) on the first day after cataract surgery and that this is below clinical concern levels for them. They added, however, that this is not the same with some Healon products (AMO), which have been shown clinically to have intermittent IOP spikes above 30 mm Hg on the first day. Most of the participants also said they would use DisCoVisc even in patients with a compromised optic disc because it is easily removed.

An added advantage is that DisCoVisc is packaged in 1-ml syringes, which seems to be more than sufficient to finish most cases.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.